ILMN Related Trader Talk
-
Roche (RHHBY) Spokesperson: Illumina (ILMN) Still 'Off the Table'
-
Illumina (ILMN) Moves Higher
-
Stocks Crossing 50-Day SMA 01/07: (INO) (OCN) (VRNG) Above; (ILMN) (LULU) (TSO) Below
-
Illumina (ILMN) Sinks as Roche Deal Put on Ice
-
Illumina (ILMN) Off Highs as Faber Raises Questions
-
Roche Prepared to Pay $66/Share for Illumina (ILMN) - Reports
-
What Gene Sequencer is Roche (RHHBY) Aiming to Buy? (ILMN) (GENE)
-
Rosetta Genomics (ROSG) Shares Active Early on Volume
-
Despite Its Hostile Moves, Takeover Speculation Follows Illumina (ILMN)
-
Stocks Crossing 50-Day SMA 10/24: (TEVA) (ARNA) (ILMN) Above; (GLW) (NFX) (IACI) Below
-
Roche (RHHBY) CEO Schwan Doesn't Comment on Illumina (ILMN) Interest, But Bid Seen Unlikely
-
Illumina (ILMN) Jumps on Speculation of New, Higher Bid from Roche
-
Life Tech (LIFE) Could Be Juicy M&A Target Following Illumina (ILMN) Bid
-
Illumina (ILMN) Competitors Jump Higher On Roche Bid (GNOM) (AFFX) (PACB) (more...)
-
Illumina (ILMN) Rivals Could Catch a Cold From its Warning
-
Illumina (ILMN) Shares Tumble Following Concerning Q3 Outlook, Suspended FY Guidance
-
JPMorgan Highlights Possible S&P 500 Additions
-
Illumina (ILMN) Smashed 10% On Implied FY11 EPS "Miss"
-
Shumway's Largest Holdings Could Be Volatile as Fund to Shutter Doors (AAPL, LVS, C, PCLN, BIDU, LYV, more)
-
Goldman Sachs Starts ILMN & WAT at Buy; AFFX at Sell
-
Illumina (ILMN) Jumps Higher
-
Illumina (ILMN): Defended following a negative pre-announcement
Back to ILMN Stock Lookup
